Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Burger

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|February 18, 1999
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitroL Chen, R A Burger, G M Zaunbrecher, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
Anticancer Research|February 24, 2001
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancerN G Cloven, A Re, M T McHale, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Molecular and Chemical Neuropathology|May 1, 1996
Immunogenetic studies in autism and related disordersR P Warren, V K Singh, R E Averett, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
Cancer Research|April 18, 2001
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expressionR V Iyengar, C A Pawlik, E J Krull, et al.
Cancer Research|June 30, 2001
A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11M M Meck, M Wierdl, L M Wagner, et al.
Gynecologic Oncology|November 1, 1994
Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitroR A Burger, E A Grosen, G R Ioli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerJ B Welsh, P P Zarrinkar, L M Sapinoso, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|February 18, 1999
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitroL Chen, R A Burger, G M Zaunbrecher, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
Anticancer Research|February 24, 2001
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancerN G Cloven, A Re, M T McHale, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Molecular and Chemical Neuropathology|May 1, 1996
Immunogenetic studies in autism and related disordersR P Warren, V K Singh, R E Averett, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
Cancer Research|April 18, 2001
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expressionR V Iyengar, C A Pawlik, E J Krull, et al.
Cancer Research|June 30, 2001
A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11M M Meck, M Wierdl, L M Wagner, et al.
Gynecologic Oncology|November 1, 1994
Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitroR A Burger, E A Grosen, G R Ioli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerJ B Welsh, P P Zarrinkar, L M Sapinoso, et al.
Pageof 8